Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-62262-1, published online 20 May 2024
The original version of this article contained an error in the name of the author Nevton Teixeira da Rosa Jr., wherein the printed order of 'Teixeira' and 'da Rosa' was reversed and the name suffix ‘Jr.’ was incorrectly stated as ‘J.’
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Liang, Z., Ralph-Epps, T., Schmidtke, M.W. et al. Author Correction: Upregulation of the AMPK-FOXO1-PDK4 pathway is a primary mechanism of pyruvate dehydrogenase activity reduction in tafazzin-deficient cells. Sci Rep 14, 14633 (2024). https://doi.org/10.1038/s41598-024-65477-4
Published:
DOI: https://doi.org/10.1038/s41598-024-65477-4
